Qiao Guoliang is a doctoral supervisor who completed his undergraduate studies at Xiangya Medical College and obtained his Ph.D. from Peking Union Medical College. He has worked for many years as a lecturer and senior researcher at the Massachusetts General Hospital (MGH) Cancer Center, Harvard University, where he has gained extensive experience in clinical and translational research in the field of malignant tumors. In 2019, he was awarded the Global Scholar-in-Training Award (GSITA) by the American Association for Cancer Research (AACR) at the AACR conference. He has led two collaborative projects between AACR and industry and received funding from the National Natural Science Foundation of China for a young investigator project. He has published over 30 research papers in internationally renowned journals such as CLIN CANCER RES, with significant achievements in the field of immune therapy for malignant tumors and comprehensive treatment of hepatobiliary and pancreatic malignancies.

Immune therapy for malignant tumors and comprehensive treatment of hepatobiliary and pancreatic malignancies

Etiology and translational treatment of hepatobiliary and pancreatic malignancies.

Member of the American Association for Cancer Research (AACR).

Member of the American Pancreatic Association (APA).